This year, prior authorization is set to become less of a headache for healthcare providers as more and more prescribers turn to automated prior authorization technologies. This is the prediction of Dr. Andrew Mellin, vice president and chief medical information officer at Surescripts.
Dr. Mellin has been a driving force in advancing strategic health IT through his work with the Surescripts Network Alliance. He has brought together industry stakeholders to focus on important issues such as population health, medication adherence and affordability, specialty medications, and interoperability.
Prior authorization is a process that requires healthcare providers to obtain approval from insurance companies before prescribing certain medications or treatments. This can often be a time-consuming and frustrating process, causing delays in patient care and adding to the administrative burden of healthcare providers.
However, with the adoption of automated prior authorization technologies, this process is expected to become much smoother and more efficient. These technologies use electronic systems to streamline the prior authorization process, reducing the need for manual paperwork and phone calls.
Dr. Mellin believes that the widespread adoption of these technologies will have a positive impact on the healthcare industry as a whole. Not only will it save time and resources for healthcare providers, but it will also improve patient care by reducing delays in treatment.
One of the key benefits of automated prior authorization is the ability to integrate with electronic health records (EHRs). This means that healthcare providers can access patient information and submit prior authorization requests directly from their EHR system, eliminating the need for separate logins and systems.
In addition, automated prior authorization can also help to improve medication adherence. By streamlining the process, patients are more likely to receive their prescribed medications in a timely manner, leading to better health outcomes.
Another important aspect of prior authorization is its impact on affordability. With the rising cost of healthcare, it is crucial to find ways to make treatments more affordable for patients. Automated prior authorization can help to reduce administrative costs for healthcare providers, which can ultimately lead to cost savings for patients.
Furthermore, the use of automated prior authorization can also improve the process for specialty medications. These medications often require prior authorization due to their high cost and potential for misuse. With automated systems, the process can be expedited, ensuring that patients receive the necessary medications without unnecessary delays.
Interoperability is another key focus for Dr. Mellin and the Surescripts Network Alliance. By bringing together industry stakeholders, they are working towards a more connected healthcare system where patient information can be easily shared between different providers and systems. This will not only improve the prior authorization process but also overall patient care.
In conclusion, the prediction of Dr. Mellin that prior authorization will become less of a pain point this year is a promising one. With the adoption of automated technologies, the process is expected to become more efficient, saving time and resources for healthcare providers and improving patient care. Dr. Mellin’s work with the Surescripts Network Alliance is a testament to the importance of collaboration and innovation in the healthcare industry. Let us look forward to a future where prior authorization is no longer a barrier to quality healthcare.
